{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T11:49:14Z","timestamp":1777204154842,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Union - PADDINGTON","doi-asserted-by":"publisher","award":["HEALTH-F2-2010-261358"],"award-info":[{"award-number":["HEALTH-F2-2010-261358"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.parkreldis.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T18:56:56Z","timestamp":1549393016000},"page":"179-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-9381","authenticated-orcid":false,"given":"Hans-Peter","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00fcrgen","family":"Huppertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Dreyhaupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymund A.C.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Durr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Bernhard","family":"Landwehrmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Kassubek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2019.02.004_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuroscience.2009.01.045","article-title":"Magnetic resonance imaging of Huntington's disease: preparing for clinical trials","volume":"164","author":"Kl\u00f6ppel","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2019.02.004_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1474-4422(14)70238-8","article-title":"Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study","volume":"13","author":"Paulsen","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data","volume":"11","author":"Tabrizi","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/jnnp-2014-309768","article-title":"Short-interval observational data to inform clinical trial design in Huntington's disease","volume":"86","author":"Hobbs","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.02.004_bib7","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/mds.23912","article-title":"Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation","volume":"26","author":"Majid","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib8","first-page":"213","article-title":"Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study","volume":"75","author":"Kassubek","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.02.004_bib9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.nicl.2018.03.027","article-title":"Reduced amygdala volumes are related to motor and cognitive signs in Huntington's disease: the IMAGE-HD study","volume":"18","author":"Ahveninen","year":"2018","journal-title":"Neuroimag. Clin."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib10","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.neuroimage.2009.10.066","article-title":"Intra- and interscanner variability of automated voxel-based volumetry based on a 3D probabilistic atlas of human cerebral structures","volume":"49","author":"Huppertz","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2019.02.004_bib11","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3174\/ajnr.A2514","article-title":"Fully automated atlas-based MR imaging volumetry in Huntington disease, compared with manual volumetry","volume":"32","author":"Kassubek","year":"2011","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib12","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/mds.26715","article-title":"Differentiation of neurodegenerative Parkinsonian syndromes by volumetric MRI analysis and support vector machine classification","volume":"31","author":"Huppertz","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.mri.2015.12.031","article-title":"Atlas based brain volumetry: how to distinguish regional volume changes due to biological or physiological effects from inherent noise of the methodology","volume":"34","author":"Opfer","year":"2016","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.parkreldis.2019.02.004_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nicl.2012.12.001","article-title":"Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: baseline results from the PADDINGTON study","volume":"2","author":"Hobbs","year":"2012","journal-title":"Neuroimag. Clin."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's disease rating scale: reliability and consistency","volume":"11","author":"Huntington\u2019s Disease Study Group","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/hbm.21304","article-title":"Quantifying change in individual subjects affected by frontotemporal lobar degeneration using automated longitudinal MRI volumetry","volume":"33","author":"Frings","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mds.25815","article-title":"TAUROS MRI Investigators, Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial","volume":"29","author":"H\u00f6glinger","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fnins.2012.00197","article-title":"Symmetric diffeomorphic modeling of longitudinal structural MRI","volume":"6","author":"Ashburner","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.biopsych.2006.06.027","article-title":"Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability","volume":"61","author":"Goldstein","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.02.004_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hbm.10123","article-title":"Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe","volume":"19","author":"Hammers","year":"2003","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib21","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuroimage.2007.09.031","article-title":"Construction of a 3D probabilistic atlas of human cortical structures","volume":"39","author":"Shattuck","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2019.02.004_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.neuroimage.2014.09.034","article-title":"Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance","volume":"104","author":"Malone","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2019.02.004_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/psp4.12097","article-title":"Modeling variability in the progression of Huntington's disease a novel modeling approach applied to structural imaging markers from TRACK-HD","volume":"5","author":"Warner","year":"2016","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib25","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","article-title":"Motor, cognitive, and functional declines contribute to a single progressive factor in early HD","volume":"89","author":"Schobel","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.02.004_bib26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/acn3.558","article-title":"An image-based model of brain volume biomarker changes in Huntington's disease","volume":"5","author":"Wijeratne","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuroimage.2015.07.087","article-title":"Assessing atrophy measurement techniques in dementia: results from the MIRIAD atrophy challenge","volume":"123","author":"Cash","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2019.02.004_bib28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/mds.26973","article-title":"Longitudinal magnetic resonance imaging in progressive supranuclear palsy: a new combined score for clinical trials","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JHD-140101","article-title":"The potential of composite cognitive scores for tracking progression in Huntington's disease","volume":"3","author":"Jones","year":"2014","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.parkreldis.2019.02.004_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nicl.2017.10.023","article-title":"Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease","volume":"17","author":"Minkova","year":"2017","journal-title":"Neuroimag. Clin."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019300355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019300355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T18:15:00Z","timestamp":1606414500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802019300355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":30,"alternative-id":["S1353802019300355"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.004","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}